Author:
Parkinson Bonny,Sermet Catherine,Clement Fiona,Crausaz Steffan,Godman Brian,Garner Sarah,Choudhury Moni,Pearson Sallie-Anne,Viney Rosalie,Lopert Ruth,Elshaug Adam G.
Funder
National Health and Medical Research Council
HCF Research Foundation
Cancer Institute NSW
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference120 articles.
1. Organisation for Economic Co-operation and Development (OECD). OECD Health Statistics 2014: frequently requested data. Paris: OECD; 2015. http://www.oecd.org/health/health-systems/oecd-health-statistics-2014-frequently-requested-data.htm . Accessed 5 Jan 2015.
2. Godman B, Malmstrom RE, Diogene E, Gray A, Jayathissa S, Timoney A, et al. Are new models needed to optimize the utilization of new medicines to sustain healthcare systems? Expert Rev Clin Pharmacol. 2015;8(1):77–94.
3. Garattini S, Bertele’ V, Godman B, Haycox A, Wettermark B, Gustafsson LL, et al. Enhancing the rational use of new medicines across European health care systems. Eur J Clin Pharmacol. 2008;64(12):1137–8.
4. Memorial Sloan Kettering Cancer Center (MSKCC). Cost of cancer drugs. New York: MSKCC; 2015. http://www.mskcc.org/research/health-policy-outcomes/cost-drugs . Accessed 6 Jan 2015.
5. Dudding A. A bitter pill: 10 drugs you can’t have. Sunday Star Times. 2008;30:C1–2.
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献